Results 151 to 160 of about 9,775 (218)

Severe Liver Dysfunction Within 48 Hours of Thionamide Therapy in Thyrotoxicosis: A Case Report. [PDF]

Am J Case Rep
Annabi C, Noor L, Mullally JA.
europepmc   +1 more source

Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025. [PDF]

Front Endocrinol (Lausanne)
Sun Y, Wang S, Zhou X.
europepmc   +1 more source

Thyroid lobe agenesis: a rare clinical finding. [PDF]

JCEM Case Rep
Diaz-Cuadrado I, Arias M, Baanante JC, Mitru C.   +3 more
europepmc   +1 more source

Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves' Disease.

J Clin Endocrinol Metab
Miyamura K, Ito M, Yamaoka H, Hisakado M, Nishihara E, Fukata S, Nishikawa M, Miyauchi A, Akamizu T.   +8 more
europepmc   +1 more source

Methimazole-Based Ionic Liquids

The Journal of Organic Chemistry, 2008
The alkylation reaction of 2-mercapto-1-methylimidazole 1a with iodoethane and chlorobutane produced S-alkylmethimazole halides 2a and 2b which were subjected to anion metathesis with two different metal salts (MA) to afford methimazole-based room-temperature ionic liquids 3a, 3b, and 3c in 82%, 85%, and 87% yields, respectively. S-Alkylation giving 2a
Amal I, Siriwardana, Ian R, Crossley, Angel A J, Torriero, Iko M, Burgar, Noel F, Dunlop, Alan M, Bond, Glen B, Deacon, Douglas R, Macfarlane   +7 more
core   +4 more sources